InterVenn Biosciences

InterVenn Biosciences

InterVenn Biosciences

InterVenn Biosciences combines AI/ML, glycoproteomics & LCMS for biomarker and target discovery.
Type
B2c
Founded
2017
Raised
$235M
Follow us
Alexa global traffic share
Latest funding
$201,000,000
Venture capital (Series C) - 2021
Amplify Partners True Ventures Softbank group +5
$34,000,000
Venture capital (Series B) - 2020
Amplify Partners True Ventures Xeraya Capital +3
Team Size
1–10
Employees
$201,000,000 Venture capital (Series C)
Pulse 2.0

InterVenn Biosciences Raises $201 Million In Series C Funding

$34,000,000 Venture capital (Series B)
e27: Asia tech news , DealStreetAsia

Malaysian VC Xeraya Capital joins US biotech firm InterVenn's US$34M round | e27